Objective To allow gene and cell therapies to evolve more quickly into biomedical sciences, it is necessary to train on i) the basic knowledge of the biology of vectors and stem cells, ii) the expertise of their production, purification and characterisation, iii) the assessment of their efficiency and bio-safety by animal experimentation, iv) the definition of the regulations where they can be transformed into new medicines and commercially exploited. Their evolution is today still far from its objective, since the insufficient knowledge of their biology, a scarce co-ordination of research projects and the absence of integration of activities of the actors operating in different concerned areas: research, industry, health products regulation and marketing. Therefore, the realisation of a multidisciplinary training programme integrating various scientific and technological approaches, is necessary to address a need of the scientific community.The activity scheduled in this proposal concerns a 2-weeks theoretical and practical course, where 32 young researchers (selected on the basis of scientific excellence) will be trained on gene transfer into animals targeting liver, brain, muscle and lung, and of imaging-monitored gene expression in alive animals. The course will gather scientists of academic and industrial institutions, coming from EU and candidate countries. It will present training and scientific innovations: for the first time the vector production technology will be combined with the in vivo evaluation. In a conference open to large public the status of the art will be presented and discussed. The course will a) allow young researchers to acquire a multidisciplinary training on vectors development including the definition of new ethical and legal frames; b) implement an environment where all concerned institutions will develop process towards the economical exploitation of new therapeutic tools. Fields of science medical and health sciencesmedical biotechnologygenetic engineeringgene therapymedical and health sciencesmedical biotechnologycells technologiesstem cells Keywords gene vectors in vivo evaluation technology transfer training Programme(s) FP6-LIFESCIHEALTH - Life sciences, genomics and biotechnology for health: Thematic Priority 1 under the Focusing and Integrating Community Research programme 2002-2006. Topic(s) LSH-2002-1.2.4-7 - Workshop on technology transfer and identification of bottlenecks (i.e. IPR, regulatory issues) for SMEs in the area of somatic gene and cell therapies Call for proposal FP6-2002-LIFESCIHEALTH See other projects for this call Funding Scheme SSA - Specific Support Action Coordinator GENETHON III EU contribution No data Address Rue de l'Internationale 1BIS BP60 EVRY France See on map Total cost No data Participants (1) Sort alphabetically Sort by EU Contribution Expand all Collapse all UNIVERSIDAD AUTONOMA DE BARCELONA Spain EU contribution No data Address Campus Universitari BELLATERRA (CERDANYOLA DEL VALLES) See on map Total cost No data
